Legislative counsels review changes to Vermont's "legally protected health care" protections, privacy rules and pharmacy redaction

Legislative counsel reviewed proposed statutory changes aimed at strengthening Vermont's protections for "legally protected health care," covering four principal changes: (1) extending state protections to acts that were lawful in other U.S. jurisdictions, (2) expanding a "noncooperation" clause to include certain federal enforcement actions, (3) tightening state limits on disclosure of protected health information (PHI) related to such care, and (4) allowing prescribers and pharmacists to request removal of practitioner names from packaging and printed materials for noncontrolled medications, staff said.

The revisions were presented as amendments to definitions and enforcement-related provisions that were first addressed in 2023's Act 13 and Act 14, which divided responsibilities between health and welfare and judiciary-related provisions. Jim Garvey of the Office of Legislative Counsel said the changes build on those earlier "shield" laws and are intended to reconcile interstate and federal interactions with Vermont's policy protecting access to reproductive and gender-affirming health care.

Why it matters: The draft changes aim to protect Vermont patients and providers from adverse actions arising from conduct that was lawful where it occurred, to limit state cooperation with out-of-state or federal efforts that would penalize protected activity, and to reduce disclosure of identifying health information that could lead to enforcement outside Vermont. The measures also respond to operational concerns raised by pharmacists about how to implement redaction requests.

Key proposals and discussion

Definition expansion (section 1). Office of Legislative Counsel staff said the bill would add language to Title 1's definition of "legally protected health care activity" to make the state's protections apply to a person who previously undertook acts or omissions in another U.S. jurisdiction that were lawful there and would have been lawful in Vermont. Garvey explained that the change is intended to give people who legitimately provided or assisted with protected care in another state the same protections when they are in Vermont, provided the acts were permissible where they occurred and would have been permissible under Vermont law.

Noncooperation (section 5). Counsel described an expansion of existing noncooperation language (now in Title 12) that arose from the 2023 shield bills. The draft would add "federal" to the list of actors with whom the state would decline to cooperate in investigations or enforcement actions targeting legally protected health care, with key exceptions: where Vermont law itself would permit investigation, or where a court order compels disclosure or cooperation. Counsel noted that court orders issued by either a Vermont state court or a federal court remain enforceable, and the draft clarifies limited exceptions such as extradition language included in the 2023 statutes.

Limits on disclosure of protected health information (section 6). The proposal would add a state-level prohibition on covered entities and business associates disclosing identifiable PHI related to legally protected health care to government entities other than Vermont state agencies and subdivisions when the information could be used to investigate or impose liability based solely on the person's involvement with protected care. Counsel said HIPAA remains the federal floor and that the draft lists exceptions where disclosure is authorized, including: patient authorization; disclosures specifically required by federal or Vermont law or court order; bona fide regulatory investigations into Vermont-licensed providers or facilities; and disclosures necessary for Vermont's Medicaid program, subject to the noncooperation provision.

Court-order nuance. Staff emphasized a technical change carried over from floor debate: language clarifies that Vermont can require state courts that order disclosure to make findings protecting individuals from use of the information to impose liability based solely on protected care, but Vermont cannot dictate what a federal court must include in a federal order.

Pharmacy redaction and liability (labeled in the draft as section 13). The bill would require, when a prescriber requests it and federal law does not prohibit removal, that pharmacists redact or remove the prescriber's name or initials from packaging and accompanying printed materials for noncontrolled medications prescribed for gender-affirming or reproductive health care. A similar allowance applies when a prescriber dispenses directly. The draft also provides civil and administrative immunity for pharmacists and staff who fail to redact when they acted without gross negligence, recklessness or intentional misconduct; ordinary negligence would not remove immunity unless it rose to those higher levels, counsel said. Pharmacists raised implementation concerns during discussion about how prescription workflows and labeling systems would accommodate such requests; counsel acknowledged the operational challenges.

What was not decided

No formal action, votes or committee decisions were recorded in the transcript. The presentation was a staff briefing and elicited questions and clarifying discussion but no formal direction beyond technical clarifications about court-order language and the scope of exceptions.

Context and background

Counsel noted that Act 13 and Act 14 (2023) created much of the current statutory framework: one bill focused on regulated professions and health data and the other on civil and criminal procedures in the judiciary. The current draft is framed as updating those shield provisions to address interstate and federal enforcement scenarios and to refine privacy and pharmacy operational concerns.

Ending / next steps

Presenters concluded the briefing after reviewing the sections and answering questions. Staff asked whether members had additional concerns; attendees signaled that the additions made sense. The transcript does not record formal amendments, votes, or a schedule for further action.